Since the early studies on CLL cell surface markers, it was clear that CLL clones with high numbers of CD38+ cells responded to surface BcR stimulation, whereas those with low CD38+ cell numbers could be classified as low responders or anergic [114,115]. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.